Business Context and Reporting Period
Company: SeaStar Medical Holding Corporation (ICU)
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2024
Event: Entry into a Material Definitive Agreement (At The Market Offering Agreement).
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the authorization of a potential equity offering.
- Proposed Offering Size: Up to $25 million in aggregate offering price.
- Commission Rate: 3.0% of the aggregate gross sales price paid to the sales agent.
- Securities Involved: Common Stock (par value $0.0001 per share).
Material Changes
On August 20, 2024, the Company entered into an At The Market Offering Agreement (ATM Agreement) with H.C. Wainwright & Co., LLC. This agreement establishes a program to sell shares of common stock from time to time through an "at the market offering" on the Nasdaq Capital Market or other existing trading markets.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company is not obligated to sell any shares under the ATM Agreement. It may suspend solicitation and offers at any time upon ten business days' prior notice. No assurance is given that the Company will sell any shares, nor regarding the price, amount, or timing of any potential sales.
Risks and Contingencies:
- Uncertainty of Execution: The filing explicitly states that no assurance can be given that any shares will be sold.
- Dilution: The sale of shares under the ATM program will result in dilution to existing shareholders.
- Costs: The Company must pay a 3.0% commission and reimburse certain legal and out-of-pocket expenses to the sales agent.
Investor Verification Checklist
- Verify the current market price of SeaStar Medical Holding Corporation (ICU) to assess potential dilution impact.
- Review the Company's most recent 10-Q or 10-K for actual cash position and liquidity needs driving this offering.
- Confirm the status of the shelf registration statement (File No. 333-275968) referenced in the filing.
- Monitor future filings for actual sales activity under the ATM program, as none are guaranteed.